Clinical Trial Update: Dose-confirmatory Bridging Study in Total Knee Replacement [Phase 3]

View source ↗

Summary

A Phase 3 dose-confirmatory bridging trial in total knee replacement assessing venous thromboembolism has the study status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: Bayer | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED